These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22115891)

  • 1. The role of bioreductive activation of antitumour anthracycline drugs in cytotoxic activity against sensitive and multidrug resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Bieg B; Paine MJ; Wolf CR; Tarasiuk J
    Eur J Pharmacol; 2012 Jan; 674(2-3):112-25. PubMed ID: 22115891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Tarasiuk J
    Eur J Pharmacol; 2013 Dec; 721(1-3):141-50. PubMed ID: 24076328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of structural factors of antitumour anthraquinone derivatives and analogues in the ability to undergo bioreductive activation by NADPH cytochrome P450 reductase: implications for increasing the activity against sensitive and multidrug-resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Bieg B; Paine MJ; Wolf CR; Tarasiuk J
    Anticancer Drugs; 2012 Apr; 23(4):393-405. PubMed ID: 22205152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreductive Activation of Antitumour Drugs, Doxorubicin and Pirarubicin, Does Not Affect Their Ability to Induce Apoptosis of Sensitive and Multidrug Resistant Leukaemia HL60 Cells.
    Kostrzewa-Nowak D; Tarasiuk J
    Anticancer Res; 2021 Mar; 41(3):1429-1438. PubMed ID: 33788734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.
    Kostrzewa-Nowak D; Paine MJ; Wolf CR; Tarasiuk J
    Br J Cancer; 2005 Jul; 93(1):89-97. PubMed ID: 15942634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Paine MJ; Korytowska A; Serwatka K; Piotrowska S; Wolf CR; Tarasiuk J
    Cancer Lett; 2007 Jan; 245(1-2):252-62. PubMed ID: 16574318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
    Maruszewska A; Kostrzewa-Nowak D; Adamus J; Czupryńska K; Maryniak D; Gebicki J; Tarasiuk J
    J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthraquinone antitumour agents, doxorubicin, pirarubicin and benzoperimidine BP1, trigger caspase-3/caspase-8-dependent apoptosis of leukaemia sensitive HL60 and resistant HL60/VINC and HL60/DOX cells.
    Nowak R; Tarasiuk J
    Anticancer Drugs; 2012 Apr; 23(4):380-92. PubMed ID: 22198116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage induced by NADPH cytochrome P450 reductase-activated idarubicin in sensitive and multidrug resistant MCF7 breast cancer cells.
    Żwierełło W; Maruszewska A; Nowak R; Kostrzewa-Nowak D; Tarasiuk J
    Pharmacol Rep; 2017 Feb; 69(1):185-195. PubMed ID: 27940401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retaining cytotoxic activity of anthrapyridone CO1 against multidrug resistant cells is related to the ability to induce concomitantly apoptosis and lysosomal death of leukaemia HL60/VINC and HL60/DOX cells.
    Nowak R; Tarasiuk J
    J Pharm Pharmacol; 2013 Jun; 65(6):855-67. PubMed ID: 23647679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour effects of selected plant polyphenols, gallic acid and ellagic acid, on sensitive and multidrug-resistant leukaemia HL60 cells.
    Maruszewska A; Tarasiuk J
    Phytother Res; 2019 Apr; 33(4):1208-1221. PubMed ID: 30838722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells.
    Gate L; Couvreur P; Nguyen-Ba G; Tapiero H
    Biomed Pharmacother; 2003 Sep; 57(7):301-8. PubMed ID: 14499178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells.
    Wada H; Saikawa Y; Niida Y; Nishimura R; Noguchi T; Matsukawa H; Ichihara T; Koizumi S
    Exp Hematol; 1999 Jan; 27(1):99-109. PubMed ID: 9923448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
    Consoli U; Priebe W; Ling YH; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M
    Blood; 1996 Jul; 88(2):633-44. PubMed ID: 8695811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
    Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines.
    Roovers DJ; van Vliet M; Bloem AC; Lokhorst HM
    Leuk Res; 1999 Jun; 23(6):539-48. PubMed ID: 10374847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour Effects of Selected Pyridinium Salts on Sensitive Leukaemia HL60 Cells and Their Multidrug Resistant Topoisomerase II-Defective HL60/MX2 Counterparts.
    Tarasiuk J; Kostrzewa-Nowak D; Żwierełło W
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antileukaemic activity of extracts from chokeberry (Aronia melanocarpa [Michx] Elliott) and mulberry (Morus alba L.) leaves against sensitive and multidrug resistant HL60 cells.
    Skupień K; Kostrzewa-Nowak D; Oszmiański J; Tarasiuk J
    Phytother Res; 2008 May; 22(5):689-94. PubMed ID: 18350513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.